Advertisement
UK markets open in 6 hours 44 minutes

  • NIKKEI 225

    37,552.16
    0.00 (0.00%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.42
    +0.06 (+0.07%)
     

  • GOLD FUTURES

    2,335.80
    -6.30 (-0.27%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,490.71
    -211.59 (-0.39%)
     

  • CMC Crypto 200

    1,429.64
    +14.88 (+1.05%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

Why Shares of Provention Bio Went Up 30.3% in November

Jim Halley, The Motley Fool
·2-min read
Why Shares of Provention Bio Went Up 30.3% in November

Shares of Provention Bio (NASDAQ: PRVB) rose 30.3% in November, according to data from S&P Global Intelligence. The pharmaceutical company closed out October at $6.94 and opened November at $7. The move up can be directly tied to the approval of Provention therapy Tzield (teplizumab-mzwv) by the Food and Drug Administration (FDA) on Nov. 17.

Continue reading